Dr. Juan Manuel Pérez, Author at SOLACI

Structural heart disease

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to...

Dr. Juan Manuel Pérez - 27 November, 2025

Structural heart disease

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to...

Dr. Juan Manuel Pérez - 26 November, 2025

Other

Atrial Fibrillation After Percutaneous Patent Foramen Ovale Closure: Cohort Study with Continuous Implantable Cardiac Monitoring

Atrial fibrillation (AF) is a recognized complication following percutaneous closure of a patent foramen ovale (PFO), with...

Dr. Juan Manuel Pérez - 18 November, 2025

Peripheral vascular disease

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although...

Dr. Juan Manuel Pérez - 13 November, 2025

Aorta

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of...

Dr. Juan Manuel Pérez - 10 November, 2025

Aorta

Safety of Prophylactic Spinal Fluid Drainage in Open and Endovascular Repair of Thoracic and Thoracoabdominal Aortic Aneurysms

Spinal cord injury remains one of the most devastating complications of thoracic and thoracoabdominal aneurysm repair, mainly...

Dr. Juan Manuel Pérez - 4 November, 2025

Coronary Disease

TCT 2025 | INFINITY–SWEDEHEART: Long-Term Outcomes of the Bioadaptive Coronary Implant Versus Drug-Eluting Stent

The bioadaptive coronary implant DynamX (Elixir Medical, California) was developed to restore normal vascular function after angioplasty,...

Dr. Juan Manuel Pérez - 29 October, 2025

Structural heart disease

TCT 2025 | SUMMIT-MAC: Transcatheter Mitral Valve Replacement with the Tendyne System in Patients with Severe Annular Calcification

The prospective, multicenter SUMMIT-MAC study evaluated the safety and efficacy of transcatheter mitral valve replacement (TMVR) using...

Dr. Juan Manuel Pérez - 29 October, 2025

Artículos del autor

Dr. Juan Manuel Pérez

Is it really necessary to monitor all patients after TAVR?

Is it really necessary to monitor all patients after TAVR?

Atrial Fibrillation After Percutaneous Patent Foramen Ovale Closure: Cohort Study with Continuous Implantable Cardiac Monitoring

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Safety of Prophylactic Spinal Fluid Drainage in Open and Endovascular Repair of Thoracic and Thoracoabdominal Aortic Aneurysms

TCT 2025 | INFINITY–SWEDEHEART: Long-Term Outcomes of the Bioadaptive Coronary Implant Versus Drug-Eluting Stent

TCT 2025 | SUMMIT-MAC: Transcatheter Mitral Valve Replacement with the Tendyne System in Patients with Severe Annular Calcification

Últimas Noticias

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Is it really necessary to monitor all patients after TAVR?

Is it really necessary to monitor all patients after TAVR?

Noticias Institucionales

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

Accesos